Health

Google’s smart contact lens is one step closer to your eyeball

Above: Google's smart contact lens

Image Credit: Google

So long Google Glass, hello Google Eye.

Google and Swiss pharmaceutical company Novartis announced this morning that they will be collaborating on bringing Google’s smart contact lens technology, which contains sensors for tracking things like blood glucose levels for diabetics, to consumers.

Google announced the smart lens project back in January, but at the time it was clear the company would need some sort of partner to make it a reality. The project came out of Google X, the skunkworks shop that also developed Google Glass and the company’s self-driving car initiative.

“Our dream is to use the latest technology in the miniaturization of electronics to help improve the quality of life for millions of people,” Google co-founder Sergey Brin said in a statement.

As part of the deal, Novartis’s eyecare arm Alcon will license Google’s smart lens technology to commercialize it. Specifically, Novartis says it’s interested in the tech’s glucose-sensing capabilities for diabetics, as well as its potential for helping people with presbyopia, who can’t read without glasses. The smart lens technology could eventually help to fix the eye’s autofocus capabilities for nearby objects, potentially by implanting it directly into the eye.

To be clear, the smart contact lens tech doesn’t do anything that Google Glass does. But now that Google has found a partner to make it a reality, it’ll be interesting to see what else Google will be able to bring right to your eyeballs soon.

More about the companies and people from this article:

Google's innovative search technologies connect millions of people around the world with information every day. Founded in 1998 by Stanford Ph.D. students Larry Page and Sergey Brin, Google today is a top web property in all major glob... read more »

Powered by VBProfiles


HealthBeat — VentureBeat’s breakthrough health tech event — is returning on Oct 27-28 in San Francisco. This year’s theme is “The connected age: Integrating data, big & small.” We’re putting long-established giants of the health care world on stage with CEOs of the nation's most disruptive health tech companies to share insights, analyze trends, and showcase breakthrough products. Purchase one of the first 50 tickets and save $400!
35 comments
Filipa Padre
Filipa Padre

I'll help for free. Cannot stand that tribe

Robert Carl Birtch
Robert Carl Birtch

Maybe. I thought Deus Ex was an awesome game. Maybe not graphically realistic, but they made up for it with that epic level of depth with regards to the storytelling. The writers were really well-educated.

Adam Reed
Adam Reed

So you don't want to be a super cyborg?

Adam Reed
Adam Reed

I'd wager that Google just might be big enough to challenge big pharma at this point.

Adam Reed
Adam Reed

Adam Jensen as an inspiration?

Adam Reed
Adam Reed

Practice good hygiene, that works :)

Rae Alton
Rae Alton

You've gotta crawl before you walk. Maybe they should convince us that Glass wasn't a monumental, expensive failure first.

Ruth Funk
Ruth Funk

Yes. Diabetes is an epidemic and this is amazing to monitor glucose

Marie Carter
Marie Carter

Have they figured out to make them amoeba free?

Onur Gunduru
Onur Gunduru

helping you with the best possible selection from millions of...

Graham Byrne
Graham Byrne

Oh Jesus Christ! I'm just waiting for a Google condom next. Super fast uploading speeds.

Robert Carl Birtch
Robert Carl Birtch

I would love them. I could finally say, "My vision is augmented." and wear a trenchcoat that makes me look bigger than I really am.

Joslyn Gibson
Joslyn Gibson

Hmm. I see (pun intended) Hippa & constitutional issues all over this. No thank you at present, pass. Great tech; don't meld it to my body. Not just yet.

Satheesh Kumar
Satheesh Kumar

Evolution...Google Glass to Google contact lenses!

Ryan Ellis
Ryan Ellis

no ... no no no ... has no one seen terminator!??!?!

Filipa Padre
Filipa Padre

it is not the ideal solution. But I doubt that big pharma would ever allow other 'ventures'. Unexplored markets are better then jeopardizing. the existing ones